Skip to main content
SpringerLink
Log in

Pathogenesis of Colorectal Cancer

  • Chapter
Colorectal Cancer

  • 363 Accesses

Abstract

Despite the new technological advancements in early diagnosis and therapeutic strategies, the clinical outcome of patients with colorectal malignancies has changed relatively little over the past 50 years [1,2]. This concept clearly underlines the need for new therapeutic approaches based on a greater understanding of the molecular basis of these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ponz de Leon M, Roncucci L The cause of colorectal cancer. Digest Liver Dis 2000; 32:426–39.

    CAS  Google Scholar 

  2. Chu KC, Tarone KE, Chow WH et al. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 1994; 86:997–1006.

    PubMed  CAS  Google Scholar 

  3. Lynch HT, Smyrk T, Lynch J An update of HNPCC (Lynch Syndrome). Cancer Genet Cytogenet 1997; 93:84–99.

    PubMed  CAS  Google Scholar 

  4. Radice P, Cama A, Mariani-Costantini R Molecular genetics of polyposis and hereditary colorectal cancer. FORUM Trends in experimental and clinical medicine 1996; 6:275–91.

    Google Scholar 

  5. Potter JD Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999; 91:916–32.

    PubMed  CAS  Google Scholar 

  6. Newcomb PA, Norfleet RG, Storer BE et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84:1572–5.

    PubMed  CAS  Google Scholar 

  7. Weinberg RA Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49:3713–21.

    PubMed  CAS  Google Scholar 

  8. Ponz de Leon M Genetic basis of tumour development. Ital J Gastroenterol 1996; 28:232–45.

    PubMed  CAS  Google Scholar 

  9. Hussain SP, Harris CC Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998

    Google Scholar 

  10. Peltomaki P Genetic basis of Hereditary Nonpolyposis Colorectal Carcinoma (HNPCC). Ann Med 1994; 26:215–9.

    PubMed  CAS  Google Scholar 

  11. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525–32.

    PubMed  CAS  Google Scholar 

  12. Kalus M Carcinoma and adenomatous polyps of the colon and rectum in biopsy and organ tissue culture. Cancer 1972; 30:972–82.

    PubMed  CAS  Google Scholar 

  13. Rembacken BJ, Fujii T, Cairns A et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. The Lancet 2000; 355:1211–4.

    CAS  Google Scholar 

  14. Roncucci L, Stamp D, Medline A et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991; 22:287–94.

    PubMed  CAS  Google Scholar 

  15. Di Gregorio C, Losi L, Fante R Histology of aberrant crypt foci in the human colon. Histopathology 1997;31:491.

    Google Scholar 

  16. Takayama T, Katsuki S, Takahashi Y et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998; 339:1277–84.

    PubMed  CAS  Google Scholar 

  17. Weisburger JH, Wynder EL Etiology of colorectal cancer with emphasis on mechanisms of action and prevention. In: Devita VT, Hellman S, Rosenberg SA. Important advances in oncology. Lippincott, Philadelphia, 1987; 197–200.

    Google Scholar 

  18. Schatzin A, Kelloff G Chemo-and dietary prevention of colorectal cancer. Eur J Cancer 1995; 31A: 1198–204.

    Google Scholar 

  19. Mafatka Z, Nebdal J, Kocianova J et al. Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years. Gut 1985; 26: 423–9.

    Google Scholar 

  20. Ponz de Leon M, Antonioli A, Ascari A et al. Incidence and familial occurrence of colorectal cancer and polyps in a Health-Care district of Northern Italy. Cancer 1987; 62: 2848–59.

    Google Scholar 

  21. Lynch HT, Smyrk T Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome). Cancer 1996; 78:1149–67.

    PubMed  CAS  Google Scholar 

  22. Baba S Recent advances in molecular genetics of colorectal cancer. World J Surg 1997; 21: 678–87.

    PubMed  CAS  Google Scholar 

  23. Rhyu MS Molecular mechanisms underlying Hereditary Nonpolyposis Colorectal Carcinoma. J Natl Cancer Inst 1996; 88: 240–51.

    PubMed  CAS  Google Scholar 

  24. Bellacosa A, Genuardi M, Anti M et al. Hereditary Nonpolyposis Colorectal Cancer: review of clinical, molecular genetics, and counseling aspects. Am J Med Genet 1996; 62:353–64.

    PubMed  CAS  Google Scholar 

  25. Naylor EW, Lebenthal E Gardner’s syndrome. Recent development in research and management. Dig Dis Sci 1980; 25: 945–59.

    PubMed  CAS  Google Scholar 

  26. Wallace MH, Phillips KS Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998; 85: 742–50.

    PubMed  CAS  Google Scholar 

  27. Moon RT, Miller JR The APC tumor suppressor protein in development and cancer. Trends Genet 1997; 13:256–8.

    PubMed  CAS  Google Scholar 

  28. Heinimann K, Mullhaupt B, Weber W et al. Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut 1998; 43:675–9.

    PubMed  CAS  Google Scholar 

  29. Behrens J, Jerchow BA, Wiirtelev M et al. Functional interaction of an Axin Homolog Conductin, with /3-catenin, APC, and GSK3. Science 1998; 280:596–9.

    PubMed  CAS  Google Scholar 

  30. Hamilton SR, Lui B, Parsons RE et al. The molecular basis of Turcofs syndrome. N Engl J Med 1995; 332:839–47.

    PubMed  CAS  Google Scholar 

  31. Spigelman AD, Arese P, Phillips RKS Polyposis: the Peutz-Jeghers syndrome. Br J Surg 1995; 82:1311–4.

    PubMed  CAS  Google Scholar 

  32. Weary PE, Gorlin RJ, Gentry WC et al. Multiple hamartoma syndrome (Cowden’s disease). Arch Derm 1972; 106:682–90.

    PubMed  CAS  Google Scholar 

  33. Subramony C, Scott-Conner CEH, Skelto D et al. Familial juvenile polyposis. Study of a kindred: evolution of polyps and relationship to gastrointestinal carcinoma. Am J Clin Pathol 1994; 102:91–7.

    PubMed  CAS  Google Scholar 

  34. Hall NR, Murday VA, Chapman P et al. Genetic linkage in Muir-Torre syndrome to the same chromosomal region as Cancer Family Syndrome. Eur J Cancer 1994; 30A:180–2.

    PubMed  CAS  Google Scholar 

  35. Haggitt RC, Reid BJ Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986; 10:871–87.

    PubMed  CAS  Google Scholar 

  36. Hanzawa M, Yoshikawa N, Tezuka T et al. Surgical treatment of Cronkhite-Canada syndrome associated with protein-losing enteropathy. Dis Colon Rectum 1998; 41:932–4.

    PubMed  CAS  Google Scholar 

  37. Lipkin M, Blattner WE, Fraumeni JF et al. Tritiated thymidine labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 1983; 43:1899–904.

    PubMed  CAS  Google Scholar 

  38. Deschner EE, Godbold J, Lynch HT Rectal epithelial cell proliferation in a group in young adults. Cancer 1988; 61:2286–90.

    PubMed  CAS  Google Scholar 

  39. Fearon ER, Vogelstein B A genetic model for colorectal tumorigenesis. Cell 1990; 61:759–67.

    PubMed  CAS  Google Scholar 

  40. Boland CR, Sato J, Appelman HD et al. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med 1995; 1:902–9.

    PubMed  CAS  Google Scholar 

  41. Muleris S, Salmon RJ, Dutrillaux AM et al. Characteristics chromosomal imbalances in 18 near-diploid colorectal tumors. Cancer Genet Cytogenet 1987; 29:289–301.

    PubMed  CAS  Google Scholar 

  42. Pathak S, Hopwood LV, Highes JI et al. Identification of colon cancer-predisposed individuals: a cytogenetic analysis. Am J Gastroenterol 1991; 86:679–84.

    PubMed  CAS  Google Scholar 

  43. Lairmore TC, Norton JA Advances in molecular genetics. Am J Surg 1997; 173:37–41.

    PubMed  CAS  Google Scholar 

  44. Shibata D, Reale MA, Lavin P et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996; 335:1727–32.

    PubMed  CAS  Google Scholar 

  45. Thiagalingam S, Lisitsyn NZ, Hamaguchi M et al. Evaluation of the FHIT gene in colorectal cancers. Cancer Res 1996; 56:2936–9.

    PubMed  CAS  Google Scholar 

  46. Takagi Y, Kohmura H, Futamura M et al. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 1996; 111: 1369–72.

    PubMed  CAS  Google Scholar 

  47. Arber N, Hibshoosh H, Moss SF et al. 1996; Increased expression of cyclin DI is an early event in multistage colorectal carcinogenesis. Gastroenterology. 1996 Mar; 110(3): 669–74 110:669–74.

    PubMed  CAS  Google Scholar 

  48. Zhu Y, Richardson JA, Parada LF et al. Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998; 94:703–14.

    PubMed  CAS  Google Scholar 

  49. Irby RB, Mao W, Coppola D et al. Activating SRC mutation in a subset of advanced human colon cancers. Nature Genet 1999; 21:187–90.

    PubMed  CAS  Google Scholar 

  50. Wang SS, Esplin ED, Li JL et al. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 1998; 282:284–7.

    PubMed  CAS  Google Scholar 

  51. Hanash SM A role for chromosome 1 in colorectal cancer. Gastroenterology 1996; 111:250–2.

    PubMed  CAS  Google Scholar 

  52. Mahmoud NN, Boolbol SK, Bilinki RT et al. APC gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res 1997; 57:5045–50.

    PubMed  CAS  Google Scholar 

  53. Kinzler KW, Vogelstein B Lessons from Hereditary Colorectal Cancer. Cell 1996; 87:159–70.

    PubMed  CAS  Google Scholar 

  54. Korinek V, Barker N, Morin J et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997; 275:1784–7.

    PubMed  CAS  Google Scholar 

  55. Rubinfeld B, Albert I, Porfiri E et al. Loss of β-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 1997; 57:4624–30.

    PubMed  CAS  Google Scholar 

  56. Jervoise H, Andreyev N, Norman AR et al. Kirsten ras mutations in patients with colorectal cancer: the multicenter “RASCAL” study. J Natl Cancer Inst 1998; 90:675–84.

    Google Scholar 

  57. Jen J, Kim H, Piantadosi S et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994; 331:213–21.

    PubMed  CAS  Google Scholar 

  58. Reale MA, Hu G, Zafar Al et al. Expression and alternative splicing of the Deleted in Colorectal Cancer (DCC) gene in normal and malignant tissues. Cancer Res 1994; 54:4493–501.

    PubMed  CAS  Google Scholar 

  59. Cho KR, Fearon ER DCC: linking tumour suppressor genes and altered cell surface interactions in cancer? Eur J Cancer 1995; 31A:1055–60.

    PubMed  CAS  Google Scholar 

  60. Lovec H, Sewing A, Lucibello FC et al. Oncogenic activity of cyclin DI revealed through cooperation with H-ras: link between cell cycle control and malignant transformation. Oncogene 1994; 9:323–6.

    PubMed  CAS  Google Scholar 

  61. Schmutte C, Yang AS, Nguyen TT et al. Mechanisms for the involvement of DNA methylation in colon carcinogenesis. Cancer Res 1996; 56:2375–81.

    PubMed  CAS  Google Scholar 

  62. Ueki T, Toyota M, Sohn T et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000; 60:1835–9.

    PubMed  CAS  Google Scholar 

  63. Han ES, Moyer MP, Naylor S et al. Mutation in the TP53 gene in colorectal carcinoma detected by polymerase chain reaction. Genes Chrom Cancer 1991; 3:313–7.

    PubMed  CAS  Google Scholar 

  64. Kahlenberg MS, Stoler DL, Basik M et al. p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers. J Natl Cancer Inst 1996; 88:1665–9.

    PubMed  CAS  Google Scholar 

  65. Shimamura A, Fisher DE p53 in life and death. Clin Cancer Res 1996; 2:435–40.

    PubMed  CAS  Google Scholar 

  66. Kaelin WG The emerging p53 gene family. J Natl Cancer Inst 1999; 91:594–8.

    PubMed  CAS  Google Scholar 

  67. Vasen HFA, van der Luijt RB, Slors JFM et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996; 348:433–5.

    PubMed  CAS  Google Scholar 

  68. Ponz de Leon M, Benatti P, Percesepe A et al. Clinical features and genotype-phenotype correlations in 41 italian families with adenomatosis coll. Ital J Gastroenterol Hepatol 1999;31:850–60.

    PubMed  CAS  Google Scholar 

  69. Samowitz WS, Thliveris A, Spirio LN et al. Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC. Cancer Res 1995; 55:3732–4.

    PubMed  CAS  Google Scholar 

  70. Spirio LN, Samowitz W, Robertson J et al. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps. Nature Genet 1998; 20:385–8.

    PubMed  CAS  Google Scholar 

  71. Powell SM, Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359:235–7.

    PubMed  CAS  Google Scholar 

  72. Knudson AG Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985; 45:1437–43.

    PubMed  CAS  Google Scholar 

  73. Westerman AM, Entius MM, de Baar E et al. Peutz-Jeghers syndrome: 78-year followup of the original family. Lancet 1999; 353:1211–5.

    PubMed  CAS  Google Scholar 

  74. Giardiello FM, Welsh SB, Hamilton SR et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987; 316:1511–4.

    PubMed  CAS  Google Scholar 

  75. Launonen V, Avizienyte E, Loukola A et al. No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas. Cancer Res 2000; 60:546–8.

    PubMed  CAS  Google Scholar 

  76. Dong SM, Kim KM, Kim SY et al. Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res 1998; 58:3787–90.

    PubMed  CAS  Google Scholar 

  77. Gruber SB, Entius MM, Petersen GM et al. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res 1998; 58:5267–70.

    PubMed  CAS  Google Scholar 

  78. Saul SH, Raffensperger E Juvenile polyposis: intramucosal signet-cell adenocarcinoma arising in a polyp at a gastrojejunostomy site. Surg Pathol 1988; 1:159–64.

    Google Scholar 

  79. Longo WE, Touloukian RJ, West AB et al. Malignant potential of juvenile polyposis coli. Report of a case and review of the literature. Dis Colon Rectum 1990; 33:980–4.

    PubMed  CAS  Google Scholar 

  80. Walpole IR, Cullity G Juvenile polyposis: a case with early presentation and death attributable to adenocarcinoma of the pancreas. Am J Med Genet 1989; 32:1–8.

    PubMed  CAS  Google Scholar 

  81. Olschwang S, Serova-Sinilnikova OM, Lenoir G et al. PTEN germ-line mutations in juvenile polyposis coll. Nature Genet 1998; 18:12–4.

    PubMed  CAS  Google Scholar 

  82. Howe JR, Roth S, Ringold JC et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280:1086–8.

    PubMed  CAS  Google Scholar 

  83. Howe JR, Ringold JC, Hughes JH et al. Direct genetic testing for Smad4 mutations in patients at risk for juvenile polyposis. Surgery 1999; 126:162–70.

    PubMed  CAS  Google Scholar 

  84. Starink TM, van der Veen JPW, Arwert F et al. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986; 29:222–33.

    PubMed  CAS  Google Scholar 

  85. Lloyd KM, Dennis M Cowden’s disease: a possible new symptom complex with multiple system involvement. Ann Intern Med 1963; 58:136–42.

    PubMed  Google Scholar 

  86. Gorlin RJ, Cohen MM, Levin LS Hamartoneoplastic syndromes. In “Syndromes of the Head and Neck”, Third Ed. New York: Oxfords University Press, 1990; 336–8,357–61.

    Google Scholar 

  87. Li J, Yen C, Liaw D et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997; 275:1943–7.

    PubMed  CAS  Google Scholar 

  88. Tsuchiya KD, Wiesner G, Cassidy SB et al. Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome. Genes Chrom Cancer 1998; 21:113–8.

    PubMed  CAS  Google Scholar 

  89. Marsh DJ, Dahia PLM, Coulon V et al. Allelic imbalance, including deletion of PTEN/ NMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chrom Cancer 1998; 21:61–9.

    PubMed  CAS  Google Scholar 

  90. Liu B, Parsons R, Papadopoulos N et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996; 2:169–74.

    PubMed  CAS  Google Scholar 

  91. Kolodner RD, Tytell JD, Schmeits JL et al. Germ-line MSH6 mutations in colorectal cancer families. Cancer Res 1999; 59:5068–74.

    PubMed  CAS  Google Scholar 

  92. Miyaki M, Konishi M, Tanaka K et al. Germline mutation of MSH6 as the cause of Hereditary Nonpolyposis Colorectal Cancer. Nature Genet 1997; 17:271–2.

    PubMed  CAS  Google Scholar 

  93. Boland CR, Sinicrope FA, Brenner DE et al. Colorectal cancer prevention and treatment. Gestroenterology 2000; 118:115–28.

    Google Scholar 

  94. Tannergard P, Lipford JR, Kolodner R et al. Mutation screening in the hMLHl gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res 1995; 55:6092–6.

    PubMed  CAS  Google Scholar 

  95. Weber TK, Conlon W, Petrelli NJ et al. Genomic DNA-based hMSH2 and hMLHl mutation screening in 32 eastern United States Hereditary Nonpolyposis Colorectal Cancer pedigrees. Cancer Res 1997; 57:3798–803.

    PubMed  CAS  Google Scholar 

  96. Ponz de Leon M, Pedroni M, Benatti P et al. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. Gut 1999; 45:32–8.

    Google Scholar 

  97. Papadopoulos N, Leach FS, Kinzler KW et al. Monoallelic mutation analysis (MAMA) for identifying germline mutations. Nature Genet 1995; 11:99–102.

    PubMed  CAS  Google Scholar 

  98. Loeb LA Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994; 54:5059–63.

    PubMed  CAS  Google Scholar 

  99. Chung DC, Rustgi AK DNA mismatch repair and cancer. Gastroenterology 1995; 109:1685–99.

    PubMed  CAS  Google Scholar 

  100. Loeb LA Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075–9.

    PubMed  CAS  Google Scholar 

  101. Jass JR Colorectal adenomas in surgical specimens from subjects with Hereditary Nonpolyposis Colorectal Cancer. Histopathology 1995; 27:263–7.

    PubMed  CAS  Google Scholar 

  102. Ahlquist DA Aggressive polyps in Hereditary Nonpolyposis Colorectal Cancer: targets for screening. Gastroenterology 1995; 108:1590–2.

    PubMed  CAS  Google Scholar 

  103. Ponz de Leon M, Delia Casa G, Benatti P et al. Frequency and type of colorectal tumors in asymptomatic high-risk individuals in families with Hereditary Nonpolyposis Colorectal Cancer. Cancer Epidemiol Biomarkers Prev 1998; 7:639–41.

    PubMed  CAS  Google Scholar 

  104. Lynch HT, Fusaro RM, Lynch J Hereditary cancer in adults. Cancer Detection and Prevention 1995; 19:219–33.

    PubMed  CAS  Google Scholar 

  105. Lynch P If aggressive surveillance in Hereditary Nonpolyposis Colorectal Cancer is now state of the art, are there any challenges left? Gastroenterology 2000; 118:969–77.

    PubMed  CAS  Google Scholar 

  106. Parsons R, Myeroff L, Liu B et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995; 55:5548–50.

    PubMed  CAS  Google Scholar 

  107. Liu B, Nicolaides NC, Markowitz S et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 1995; 9:48–55.

    PubMed  CAS  Google Scholar 

  108. Strand M, Earley MC, Crouse GF et al. Mutations in the MSH3 gene preferentially lead to deletions within tracts of simple repetitive DNA in Saccharomyces cervisiae. Proc Natl Acad Sci 1995; 92:10418–21.

    PubMed  CAS  Google Scholar 

  109. Perucho M Microsatellite instability: the mutator that mutates the other mutator. Nature Med 1996; 2:630–1.

    PubMed  CAS  Google Scholar 

  110. Yagi OK, Akiyama Y, Nomizu T et al. Proapoptotic gene BAX is frequently mutated in Hereditary Nonpolyposis Colorectal Cncers but not in adenomas. Gastroenterology 1998; 268-74.

    Google Scholar 

  111. Salahshor S, Kressner U, Fischer H et al. Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer 1999; 81:190–3.

    PubMed  CAS  Google Scholar 

  112. Cunningham JM, Christensen ER, Tester DJ et al. Hypermethylation of the hMLHl promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58:3455–60.

    PubMed  CAS  Google Scholar 

  113. Deng G, Chen A, Hong J et al. Methylation of CpG in a small region of the hMLHl promoter invariably correlates with the absence of gene expression. Cancer Res 1999; 59:2029–33.

    PubMed  CAS  Google Scholar 

  114. Herman JG, Umar A, Polyak K et al. Incidence and functional consequences of hMLHl promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci 1998; 95:6870–5.

    PubMed  CAS  Google Scholar 

  115. Kuismanen SA, Holmberg MT, Salovaara R et al. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 2000; 156:1773–9.

    PubMed  CAS  Google Scholar 

  116. Williams NN, Daly JM Flow cytometry and prognostic implications in patients with solid tumors. Surgery Gynecology Obstetrics 1990; 171:257–66.

    CAS  Google Scholar 

  117. Cahill DP, Lengauer C, Yu J et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998; 392:300–3.

    PubMed  CAS  Google Scholar 

  118. Orr-Weaver TL, Weinberg RA A checkpoint on the road to cancer. Nature 1998; 392:223–4.

    PubMed  CAS  Google Scholar 

  119. Ekbom A, Helmick C, Zack M et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990; 3223:1228–33.

    Google Scholar 

  120. Choi PM, Zelig MP Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994; 35:950–4.

    PubMed  CAS  Google Scholar 

  121. Goldman H Significance and detection of dysplasia in chronic colitis. Cancer 1996; 78:2261–3.

    PubMed  CAS  Google Scholar 

  122. Biasco G, Miglioli M, Minarini A et al. Rectal cell renewal as biological marker of cancer risk in ulcerative colitis. In “Precancerous lesions of the gastrointestinal tract”, edited by Sherlock P, Morson BD, Barbara L, Veronesi U, Raven Press, New York, 1983; 261–8.

    Google Scholar 

  123. Wright CL, Riddell RH The pathology and politics of dysplasia in ulcerative colitis. Current Opinion in Gastroenterology 1998; 11:4–10.

    Google Scholar 

  124. Walsh SV, Loda M, Torres CM et al. P53 and p catenin expression in chronic ulcerative colitis-associated polyposis dysplasia And sporadic adenomas. An immunohistochemical study. Am J Surg Pathol 1999; 23:963–9.

    PubMed  CAS  Google Scholar 

  125. Gibson P, Rosella O, Nov R et al. Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer. Gut 1995; 36:857–63.

    PubMed  CAS  Google Scholar 

  126. Heinen CD, Noffsinger AE, Belli J et al. Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation. Genes Chrom Cancer 1997; 19:170–5.

    PubMed  CAS  Google Scholar 

  127. Rabinovitch PS, Dziadon S, Brentnall TA et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999; 59:5148–53.

    PubMed  CAS  Google Scholar 

  128. Cawkwell L, Sutherland F, Murgatroyd H et al. Defective hMSH2/hMLHl protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut 2000; 46:367–369.

    PubMed  CAS  Google Scholar 

  129. Hsieh CJ, Klump B, Holzmann K et al. Hypermethylation of the pl6INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998; 58:3942–5.

    PubMed  CAS  Google Scholar 

  130. Lyda MH, Noffsinger A, Belli J et al. Multifocal neoplasia involving the colon and appendix in ulcerative colitis: pathological and molecular features. Gastroenterology 1998; 115:1566–73.

    PubMed  CAS  Google Scholar 

  131. Mecklin JP Frequency of hereditary colorectal carcinoma. Gastroenterology 1987; 93:1021–5.

    PubMed  CAS  Google Scholar 

  132. Lovett E Family studies in cancer of the colon and rectum. Br J Surg 1976; 63:13–8.

    PubMed  CAS  Google Scholar 

  133. Woolf CM A genetic study of carcinoma of the large bowel. Am J Hum Genet 1958; 10:42–7.

    PubMed  CAS  Google Scholar 

  134. Ponz de Leon M, Sassatelli R, Sacchetti C et al. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res 1989; 49:4344–8.

    PubMed  CAS  Google Scholar 

  135. Laken SJ, Petersen GM, Gruber SB et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 1997; 17:79–83.

    PubMed  CAS  Google Scholar 

  136. Lothe RA, Hektoen M, Johnsen H et al. The APC gene 11307 K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer. Cancer Res 1998;58:2923–4.

    PubMed  CAS  Google Scholar 

  137. Prior TW, Chadwick RB, Papp AC et al. The 11307 K polymorphism of the APC gene in colorectal cancer. Gastroenterology 1999; 116:58–63.

    PubMed  CAS  Google Scholar 

  138. White RL Excess risk of colon cancer associated with a polymorphism of the APC gene? Cancer Res 1998; 58:4038–9.

    PubMed  CAS  Google Scholar 

  139. Warner E, Foulkes W, Goodwin P et al. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 1999;91:1241–7.

    PubMed  CAS  Google Scholar 

  140. Osorio A, Barroso A, Martinez B et al. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer 2000; 82:1266–70.

    PubMed  CAS  Google Scholar 

  141. Morson BC, Bussey HJR, Day DW et al. Adenomas of large bowel. Cancer Surv 1983; 2:451–77.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Modena and Reggio Emilia, Policlinic, Via del Pozzo 71, 41100, Modena, Italy

    Dr. Maurizio Ponz de Leon

Authors
  1. Dr. Maurizio Ponz de Leon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ponz de Leon, M. (2002). Pathogenesis of Colorectal Cancer. In: Colorectal Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56008-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56008-8_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62762-0

  • Online ISBN: 978-3-642-56008-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation